Testing effectiveness (Phase 2)Looking for participantsNCT05892614
What this trial is testing
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Who this might be right for
Interstitial Lung Disease
aTyr Pharma, Inc. 25